Skip to main content
BCYC logo
BCYC
(NASDAQ)
Bicycle Therapeutics plc
$5.05-- (--)
Loading... - Market loading

Bicycle Therapeutics (BCYC) Stock Price & Financial Analysis

Bicycle Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.79 - $5.08
52-Week High$9.55
52-Week Low$4.24
Open$4.79
Volume324.69K
Average Volume (3M)324.69K
Market Cap349.98M
Shares Outstanding69.30M
Price to Sales (P/S)11.98
Price to Book (P/B)0.55
EV/EBITDA1.23
Revenue (TTM)28.34M
Net Income (TTM)-250.66M
Free Cash Flow (TTM)-241.87M
EPS (TTM)$-3.62
Profit Margin-884.51%
Operating Margin-1023.86%
Return on Equity (ROE)-40.53%
Debt to Equity0.01
50-Day MA$5.48
200-Day MA$6.91
52-Week Change-37.58%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bicycle Therapeutics

What is the current stock price for BCYC?

As of the latest trading session, BCYC stock trades at $5.05. The 52-week range is $4.24–$9.55, with a day range of $4.79–$5.08.

What is the P/E ratio for BCYC?

The P/E ratio (Price-to-Earnings) for BCYC is shown in the Key Statistics section. This valuation metric helps compare Bicycle Therapeutics plc to industry peers.

Does BCYC pay dividends?

Bicycle Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BCYC?

Based on 5 analysts, the consensus for BCYC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BCYC?

Bicycle Therapeutics's market capitalization is $350.0M, classifying it as a small-cap company. Bicycle Therapeutics operates in the Healthcare sector within the Biotechnology industry.